Endocrine oncology

PDLIM7 Promotes Tumor Metastasis in Papillary Thyroid Carcinoma via Stabilizing Focal Adhesion Kinase Protein

ThyroidPublished Mechanistic study

Authors' conclusion

PDLIM7 function as an oncoprotein in PTC to promote metastasis, and a novel underlying mechanism is proposed that PDLIM7 keeps FAK protein from proteosome-dependent degradation.

Study context

Population
Patients with PTC at The Second Affiliated Hospital of Guilin Medical University (n=80) and 512 PTC samples from The Cancer Genome Atlas; PTC cell lines; TPC-1 xenografts80 patients + 512 TCGA samples
Comparison
PDLIM7 knockdown vs control in PTC cell lines and xenografts; PDLIM7 expression in PTC tissues
Methodological detailsin vitro functional assays, xenograft mouse model, clinical cohort and TCGA database analysis
  • In vitro functional assays
  • Xenograft mouse model
  • Clinical cohort and TCGA database analysis

Main finding

As reported in the abstract

  • PDLIM7 protein frequently upregulated in PTC tissues and cells; overexpression associated with advanced clinicopathological characteristics
  • PDLIM7 knockdown inhibits proliferation, migration and invasion in PTC cell lines in vitro
  • PDLIM7 knockdown hinders growth and metastasis of TPC-1 xenografts in vivo
  • PDLIM7 colocalizes with focal adhesion kinase (FAK) and integrin alpha V (ITGAV); knockdown causes FA disassembly and proteosome-dependent FAK degradation

Original publication

PDLIM7 Promotes Tumor Metastasis in Papillary Thyroid Carcinoma via Stabilizing Focal Adhesion Kinase Protein. Thyroid. Published 20 February 2024. doi:10.1089/thy.2023.0497

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.